Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced
D003520:Cyclophosphamide; D005169:Factor VIII